Drugs / SKI2670
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02202408 | Jun 2014 → Aug 2016 | endometriosis | SK Chemicals Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SKI2670 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02202408 ↗ |
| Route | Oral | “after oral administration” NCT02202408 ↗ |